04/21/2026
The Standard for Clinician-Guided Wellness
The Substance Access BEI isn't just about providing a wellness tool; it’s about the clinical conversation. 🤝 A core requirement of the 2026 pilot is "shared decision-making." This means a qualified physician must review a patient's current medications, discuss potential risks and benefits, and determine if h**p-derived wellness is a safe and appropriate addition to their specific health journey. This clinician-led approach is a milestone for the industry, bridging the gap between traditional healthcare and botanical wellness. By keeping these discussions within the doctor-patient relationship, the program ensures that every step taken is science-driven and safety-focused. At Edify, we believe professional guidance is the key to unlocking the true potential of nature-based support. 🌿
Learn more details in the first comment.
Disclaimer: This content is for educational purposes only and does not constitute medical advice. Edify is an independent entity and is not affiliated with, endorsed by, or a part of CMS or the federal Medicare program. The Substance Access BEI is a pilot program for specific participants. These statements have not been evaluated by the FDA, and information shared is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare provider regarding clinical decisions.